These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 35860380)

  • 1. Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Xue L; Deng Z; Luo W; He X; Chen Y
    Front Cell Infect Microbiol; 2022; 12():759306. PubMed ID: 35860380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
    Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies.
    Jayachandran M; Qu S
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1189-1204. PubMed ID: 37840104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD.
    Gupta M; Krishan P; Kaur A; Arora S; Trehanpati N; Singh TG; Bedi O
    Inflamm Res; 2021 Jul; 70(7):765-776. PubMed ID: 34212214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect.
    Qiu XX; Cheng SL; Liu YH; Li Y; Zhang R; Li NN; Li Z
    World J Gastroenterol; 2024 Feb; 30(8):833-842. PubMed ID: 38516241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.
    Del Barrio M; Lavín L; Santos-Laso Á; Arias-Loste MT; Odriozola A; Rodriguez-Duque JC; Rivas C; Iruzubieta P; Crespo J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
    Craven L; Rahman A; Nair Parvathy S; Beaton M; Silverman J; Qumosani K; Hramiak I; Hegele R; Joy T; Meddings J; Urquhart B; Harvie R; McKenzie C; Summers K; Reid G; Burton JP; Silverman M
    Am J Gastroenterol; 2020 Jul; 115(7):1055-1065. PubMed ID: 32618656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation in NAFLD Treatment.
    Abenavoli L; Maurizi V; Rinninella E; Tack J; Di Berardino A; Santori P; Rasetti C; Procopio AC; Boccuto L; Scarpellini E
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363516
    [No Abstract]   [Full Text] [Related]  

  • 9. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
    Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
    Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach.
    Stols-Gonçalves D; Mak AL; Madsen MS; van der Vossen EWJ; Bruinstroop E; Henneman P; Mol F; Scheithauer TPM; Smits L; Witjes J; Meijnikman AS; Verheij J; Nieuwdorp M; Holleboom AG; Levin E
    Gut Microbes; 2023 Dec; 15(1):2223330. PubMed ID: 37317027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response.
    Delaune V; Orci LA; Lacotte S; Peloso A; Schrenzel J; Lazarevic V; Toso C
    Expert Opin Biol Ther; 2018 Oct; 18(10):1061-1071. PubMed ID: 30173562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view.
    Chen HT; Huang HL; Li YQ; Xu HM; Zhou YJ
    World J Gastroenterol; 2020 Apr; 26(16):1901-1911. PubMed ID: 32390701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.
    Ebrahimzadeh Leylabadlo H; Ghotaslou R; Samadi Kafil H; Feizabadi MM; Moaddab SY; Farajnia S; Sheykhsaran E; Sanaie S; Shanehbandi D; Bannazadeh Baghi H
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):613-627. PubMed ID: 31828683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.
    Zhou D; Pan Q; Shen F; Cao HX; Ding WJ; Chen YW; Fan JG
    Sci Rep; 2017 May; 7(1):1529. PubMed ID: 28484247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
    Aron-Wisnewsky J; Warmbrunn MV; Nieuwdorp M; Clément K
    Gastroenterology; 2020 May; 158(7):1881-1898. PubMed ID: 32044317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
    Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
    Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.